Eric M. Meslin
Eric is the partner lead on policy consultation and bioethics advisory practice.
Eric has had a diverse 35-year career in clinical, academic, government and not-for profit settings. A common thread throughout has been a focus on the ethical, social and policy implications of health, science, and technology.
His academic resume includes15 years as Founding Director of the Indiana University Center for Bioethics, Associate Dean for Bioethics in the IU School of Medicine, tenured Full Professor of Medicine, and of Philosophy and IU’s first Endowed Professor of Bioethics.
He has held academic positions at the University of Toronto, University of Western Australia, Université de Toulouse. Eric has had an equally productive policy leadership career including as the President and CEO of the Council of Canadian Academies, Bioethics Research Director of the Ethical, Legal, and Social Implications (ELSI) program at the National Human Genome Research Institute in the early years of the Human Genome Project, and Executive Director of the U.S. National Bioethics Advisory Commission established by President Bill Clinton.
Eric is a highly sought after advisor to World Health Organization, OECD, UNESCO, Centers for Disease Control and Prevention, Canadian Institutes of Health Research, Genome Canada, and the UK Biobank.
Qualifications
- MA in Philosophy/Bioethics, Georgetown University, Washington DC (1985)
- BA in Philosophy, York University, Toronto, Canada (1983)
- ICD.D certification in corporate governance, University of Toronto Rotman School of Management (2023)
Honours and Awards
- Fellow, Royal Society of Canada [FRSC] (2020)
- Fellow, The Hastings Center, New York (2020)
- Fellow, Canadian Academy of Health Sciences [FCAHS] (2015)
- Chevalier de L’Ordre National du Mérite, République Française (2007)
- U.S. National Institutes of Health Merit Award (1997)
Experience
- President and CEO, Council of Canadian Academies, Canada (2016-23)
- Member, Biodigital Convergence Working Group on Social Risk and Ethics, International Electrotechnical Commission, Geneva (2021-23)
- Vice-Chair, Ethics and Governance Council, UK BIOBANK 2015-18)
Publications
200+ publications including peer-reviewed articles and abstracts, edited books, book chapters, technical reports and commissioned studies. Recent publications include:
- Evans W, Meslin EM, Kai J, Qureshi N Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care. Journal of Personalized Medicine. 2024; 14(4):41
- Meslin EM. Musing on Research Ethics: Progress, Inclusion, and Good Governance. In: Roger Brownsword, Deryck Beyleveldd, Marcus Düwell (eds.) Research Handbook on Law, Governance and Bioethics. Edward Elgar Publishing, (in press)
- Meslin EM, Creutzberg T. MAID as a Case Study in Evidence for Policy Making: An Account of the CCA Assessment on Medical Assistance in Dying. Healthcare Management Forum(published online. DOI:10.1177/084047042211408556)
- O’Doherty K, Shabani M, Dove ES, Bentzen HB, Borry P, Burgess MM, Chalmers D, De Vries J, Eckstein J, Fullerton SM, Juengst E, Kato K, Kaye J, Knoppers BM, Koenig BA, Manson SM, McGrail K, McGuire AL, Meslin EM, Nicol D, Prainsack B, Terry SF, Thorogood A, Burke W. Towards better governance of human genomic data. Nature Genetics 2021; 53:2–8. Meslin EM. The Once and Future Role of Policy Advice for Health Regulation by Experts and Advisory Committees, In: Graeme Laurie, Edward Dove, et al eds. Cambridge Handbook of Health Research Regulation, Cambridge University Press, 2021: 215-226.
Contact Eric
LDMH Partners (North America)
Coming soon
E-Mail: eric@ldmhpartners.com
Tel.: +1 613 355 4798
